FIELD: medicine.
SUBSTANCE: invention describes N-hydroxyformamide derivative of formula
or its pharmaceutically acceptable salt. ADAM17 inhibitor and medication, which contains formula (I) compound or its pharmaceutically acceptable salt as active component, are also disclosed.
EFFECT: improved properties of derivative.
4 cl, 2 tbl, 30 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR SUPPORTING FUNCTION OF PLATELETS | 2011 |
|
RU2578607C2 |
| 2-AMINOBENZOXAZOLE CARBOXAMIDES AS 5-HT3 MODULATORS | 2007 |
|
RU2448105C2 |
| ANTIBACTERIAL AGENT | 2000 |
|
RU2269525C2 |
| PIPERIDINE- AND PIPERAZINE-SUBSTITUTED N-HYDROXYFORMAMIDES AS INHIBITORS OF METALLOPROTEINASES | 2001 |
|
RU2283306C2 |
| 2,5-DISUBSTITUTED 3-MERCAPTOPENTANIC ACIDS AND METHOD OF OBTAINING THEM | 2003 |
|
RU2365583C2 |
| CETP INHIBITORS | 2006 |
|
RU2513107C2 |
| PIPERIDINE DERIVATIVES AS OREXIN RECEPTOR ANTAGONISTS | 2015 |
|
RU2669701C2 |
| NITROGEN-CONTAINING HETEROCYCLIC AMIDE AND ITS USE FOR MEDICAL PURPOSES | 2019 |
|
RU2789670C2 |
| NEW QUINOLINE COMPOUNDS | 2018 |
|
RU2810113C2 |
| MACROCYCLIC INTEGRASE INHIBITORS | 2011 |
|
RU2567385C2 |
